Beranda › Meduloblastoma › California
Uji klinis Meduloblastoma di California
6 studi untuk Meduloblastoma mencari peserta di lokasi di California.
Kota di California
Teks studi resmi (Bahasa Inggris)
Liothyronine in Combination With BIT Regimen for Medulloblastoma With or Without Minimal Residual Disease
- University of California, San Francisco, San Francisco
Menerima pesertaFase 1/2
Usia 1 hingga 25 · Semua jenis kelamin · Diperbarui 28 Sep 2026 · NCT07346157Molecular and Clinical Risk-Directed Therapy for Infants and Young Children With Newly Diagnosed Medulloblastoma
- Lucille Packard Children's Hospital Stanford, Palo Alto
Menerima pesertaFase 2
59 Months · Semua jenis kelamin · Diperbarui 15 Sep 2026 · NCT05535166GPC2-CAR T Cell Therapy for Relapsed or Refractory Medulloblastoma in Children and Young Adults
- Lucile Packard Children's Hospital Stanford, Palo Alto
Menerima pesertaFase 1
Usia 1 hingga 30 · Semua jenis kelamin · Diperbarui 11 Sep 2026 · NCT07087002A Study of Treatment for Medulloblastoma Using Sodium Thiosulfate to Reduce Hearing Loss
- Loma Linda University Medical Center, Loma Linda
- Miller Children's and Women's Hospital Long Beach, Long Beach
- Children's Hospital Los Angeles, Los Angeles
- dan 6 lainnya
Menerima pesertaFase 3
Usia 4 hingga 21 · Semua jenis kelamin · Diperbarui 25 Agu 2026 · NCT05382338DFMO as Maintenance Therapy for Molecular High/Very High Risk and Relapsed Medulloblastoma
- UCSF Benioff Children's Hospital Oakland, Oakland
- UC Davis Comprehensive Cancer Center, Sacramento
- Rady Children's Hospital, San Diego
- dan 1 lainnya
Menerima pesertaFase 2
Hingga usia 21 · Semua jenis kelamin · Diperbarui 12 Agu 2026 · NCT04696029Individualized Treatment Plan in Children and Young Adults With Relapsed Medulloblastoma and Ependymoma
- Children's Hospital of Los Angeles, Los Angeles
- Rady Children's Hospital, San Diego
- University of California, San Francisco, San Francisco
Menerima peserta
12 Months – 39 Years · Semua jenis kelamin · Diperbarui 11 Agu 2026 · NCT05057702Dari ClinicalTrials.gov, data diambil 5 Okt 2026. Setiap studi menetapkan kriteria kelayakannya sendiri; tim studi yang menentukan siapa yang bisa bergabung.